Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/31/1969
US1051
mi
from
Cincinnati, OH
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/31/1969
US1051
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/31/1969
US1333
mi
from
Tucson, AZ
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/31/1969
US1333
mi
from
Tucson, AZ
Click here to add this to my saved trials
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/31/1969
US1386
mi
from
Wichita, KA
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/31/1969
US1386
mi
from
Wichita, KA
Click here to add this to my saved trials
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/31/1969
US1015
mi
from
Baltimore, MD
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/31/1969
US1015
mi
from
Baltimore, MD
Click here to add this to my saved trials
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/31/1969
US1334
mi
from
Middleburg Heights, OH
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/31/1969
US1334
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/31/1969
US1133
mi
from
Washington,
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/31/1969
US1133
mi
from
Washington,
Click here to add this to my saved trials
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/31/1969
US1160 Renew Behavioral Health, Inc.
mi
from
Long Beach, CA
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/31/1969
US1160 Renew Behavioral Health, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated:  12/31/1969
US1385 Ericksen Research And Development
mi
from
Clinton, MS
Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
Interventional, Randomised, Double-blind, Placebo-controlled, Active Reference (Fluoxetine), Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years, With Major Depressive Disorder (MDD)
Status: Enrolling
Updated: 12/31/1969
US1385 Ericksen Research And Development
mi
from
Clinton, MS
Click here to add this to my saved trials
The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder
Relationship Among Changes in Brain Network Activation, Changes in Core Depressive and Cognitive Symptoms and Safety and Tolerability in Adults With Major Depressive Disorder Treated With Open-Label, Flexible-Dose Vortioxetine
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder
Relationship Among Changes in Brain Network Activation, Changes in Core Depressive and Cognitive Symptoms and Safety and Tolerability in Adults With Major Depressive Disorder Treated With Open-Label, Flexible-Dose Vortioxetine
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder
Relationship Among Changes in Brain Network Activation, Changes in Core Depressive and Cognitive Symptoms and Safety and Tolerability in Adults With Major Depressive Disorder Treated With Open-Label, Flexible-Dose Vortioxetine
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Skokie, IL
The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder
Relationship Among Changes in Brain Network Activation, Changes in Core Depressive and Cognitive Symptoms and Safety and Tolerability in Adults With Major Depressive Disorder Treated With Open-Label, Flexible-Dose Vortioxetine
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Skokie, IL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Southern California Research
mi
from
Beverly Hills, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Southern California Research
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
ATP Clinical Research, Inc.
mi
from
Costa Mesa, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
ATP Clinical Research, Inc.
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute
mi
from
Los Alamitos, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Excell Research, Inc.
mi
from
Oceanside, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Anderson Clinical Research
mi
from
Redlands, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Anderson Clinical Research
mi
from
Redlands, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Thomas M. Shiovitz, M.D., Inc., DBA California Neuroscience Research Medical Group, Inc.
mi
from
Sherman Oaks, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Thomas M. Shiovitz, M.D., Inc., DBA California Neuroscience Research Medical Group, Inc.
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Viking Clinical Research
mi
from
Temecula, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Viking Clinical Research
mi
from
Temecula, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Pacific Clinical Research Medical
mi
from
Upland, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pacific Clinical Research Medical
mi
from
Upland, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Comprehensive Psychiatric Care
mi
from
Norwich, CT
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Comprehensive Psychiatric Care
mi
from
Norwich, CT
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Meridien Research
mi
from
Bradenton, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Bradenton, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
MD Clinical
mi
from
Hallandale Beach, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
MD Clinical
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Meridien Research
mi
from
Lakeland, FL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Meridien Research
mi
from
Lakeland, FL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Atlanta Center for Medical Research
mi
from
Atlanta, GA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Adams Clinical Trials LLC
mi
from
Watertown, MA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Adams Clinical Trials LLC
mi
from
Watertown, MA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Altea Research
mi
from
Las Vegas, NV
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Altea Research
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Bioscience Research, Llc
mi
from
Mount Kisco, NY
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Bioscience Research, Llc
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Eastside Comprehensive Medical Center
mi
from
New York, NY
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Eastside Comprehensive Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Finger Lakes Clinical Research
mi
from
Rochester, NY
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Finger Lakes Clinical Research
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Neuro-Behavioral Clinical Research, Inc.
mi
from
Canton, OH
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research Center
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
IPS Research
mi
from
Oklahoma City, OK
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
IPS Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical NeuroScience Solutions, Inc.
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Donald J. Garcia Jr., MD
mi
from
Austin, TX
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Donald J. Garcia Jr., MD
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Northwest Clinical Research Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Pharmacology Research Institute
mi
from
Encino, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pharmacology Research Institute
mi
from
Encino, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Synergy San Diego
mi
from
Lemon Grove, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Synergy San Diego
mi
from
Lemon Grove, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
University of Arizona Department of Psychiatry
mi
from
Tucson, AZ
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
University of Arizona Department of Psychiatry
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Woodland International Research Group, Inc.
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Woodland Research Northwest
mi
from
Rogers, AR
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Woodland Research Northwest
mi
from
Rogers, AR
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
California Pharmaceutical Research Institute, Inc
mi
from
Anaheim, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
California Pharmaceutical Research Institute, Inc
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
ProScience Research Group
mi
from
Culver City, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
ProScience Research Group
mi
from
Culver City, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Behavioral Research Specialists, LLC
mi
from
Glendale, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Synergy Clinical Research Center of Escondido
mi
from
Lemon Grove, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Synergy Clinical Research Center of Escondido
mi
from
Lemon Grove, CA
Click here to add this to my saved trials
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  12/31/1969
Pacific Research Partners, LLC
mi
from
Oakland, CA
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 12/31/1969
Pacific Research Partners, LLC
mi
from
Oakland, CA
Click here to add this to my saved trials